Researchers created a liquid gel that quickly transforms into a spongelike antimicrobial foam to stymie severe bleeding and ultimately preserve lives.

FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of ...

All of us at Modern Meadow have a passion for technology and innovation, and I am proud to lead us into our next chapter as ...

Attivare Therapeutics, a startup founded by researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering, ...

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound(TM) Product from Sequence LifeScience, Inc.

Bashur uses scanning electron microscopy, or SEM, in research in his lab that focuses on vascular tissue engineering that also incorporates drug delivery approaches. The SEM with the new cryo-feature ...

Without proper medical intervention, injuries sustained from traffic collisions, serious workplace accidents or weapons may ...

The material commonly used in vaginal mesh implants starts to degrade within 60 days of being implanted in the pelvis, ...

The development has the potential to enhance safety and minimize environmental impact, according to researchers. During oil ...

Mycelium Muse: discover Reishi™ from MycoWorks and Paragone Agency MycoWorks, a pioneering biotech company, in collaboration ...

Attivare Therapeutics, a startup founded by researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering, received a license from the Wyss Institute to use biomaterials developed at ...